Latest filing published 04 Mar 2022 for Nuance Communications, Inc..
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Mark R. Laret (senior executive) discloses dealings in 2 companies, chiefly Nuance Communications, Inc. and Varian Medical Systems Inc. We count 64 filings; the first trade dates from 1 January 2016 and the latest from 4 March 2022.
No open-market purchase appears, only 50 sales worth €2.6M. Other entries cover 7 share grants and 5 option exercises.
The newest entry dates from 4 March 2022: a transaction, in Nuance Communications, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations